ArticleFrontiers in molecular biosciences2025

Computational molecular insights into ibrutinib as a potent inhibitor of HER2-L755S mutant in breast cancer: gene expression studies, virtual screening, docking, and molecular dynamics analysis.

Tamizhini Loganathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.